| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 05/06/2004 | EP1181027B1 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 05/06/2004 | EP1165138B1 Programmed controlled ovarian stimulation protocol using oral contraceptives |
| 05/06/2004 | EP1137409B1 Compositions and methods for amelioration of human female sexual dysfunction |
| 05/06/2004 | EP0775155B1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 05/06/2004 | CA2503391A1 Immediate release topical pharmaceutical formulation for enhancement of female sexual desire and responsiveness |
| 05/06/2004 | CA2502607A1 Method for treating erectile dysfunction and increasing libido in men |
| 05/05/2004 | CN1494552A Flt 4 (VEGFR-3) as target for tumor imaging and anti-tumor therapy |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494526A Inhibitor of monoamine uptake |
| 05/05/2004 | CN1494425A Carboxamide derivatives as therapeutic agents |
| 05/05/2004 | CN1494423A Benzimidazole derivatives as therapeutic agents |
| 05/05/2004 | CN1493676A Enrich yin invigorate yang dispel disease medicated wine |
| 05/05/2004 | CN1493349A Medicine composition for treating mastopathy hyperplasia and its preparing process |
| 05/05/2004 | CN1493346A Functional medical wine for treating various diseases |
| 05/05/2004 | CN1493298A Ginseng stem leaf total saponin drip pill and its preparation method |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1148227C Therapeutic compound and its application |
| 05/05/2004 | CN1148215C Kidney benefiting belt |
| 05/05/2004 | CN1148204C Chinese medicine preparation for treating mastoplasia and its preparing process |
| 05/05/2004 | CN1148202C Preparation for eliminating bursa |
| 05/05/2004 | CN1148185C Inhibitor for generation of 3-deoxyglucurone |
| 05/05/2004 | CN1148181C Use of flavnolignanes for the prepn. of medicaments with antiproliferative activity in uterus, ovary and breast |
| 05/05/2004 | CN1148172C Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730664 The side-effects of chemotherapy are suppressed or reduced |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | CA2183234C Agent for prophylaxis and treatment of thromboxane a2-mediated diseases |
| 05/04/2004 | CA2069600C Fatty acid compositions |
| 04/29/2004 | WO2004035766A2 In vitro synchronisation of nuclear and cytoplasmatic maturation of oocytes involving addition and removal of phosphodiesterase type 3 inhibitor |
| 04/29/2004 | WO2004035584A1 Pharmaceutical compounds specifically inhibiting smooth muscle pde5, pharmaceutical compositions containing same and therapeutic uses thereof |
| 04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
| 04/29/2004 | WO2004035072A2 Identifying and treating vaginal infections |
| 04/29/2004 | WO2004035036A1 A method of treating vasomotor symptoms comprising a compound having norepinephrine reuptake inhibitor activity and 5-ht2a antagonistic activity |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2004000230A3 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders |
| 04/29/2004 | WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003013537A9 Irinotecan for treatment of cancer |
| 04/29/2004 | WO2003013536A9 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 04/29/2004 | WO2003013535A9 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 04/29/2004 | WO2003013534A9 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 04/29/2004 | WO2003013533A9 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082666 Antiserotonine agents |
| 04/29/2004 | US20040082658 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 04/29/2004 | US20040082642 Novel estrogen receptor ligands and method III |
| 04/29/2004 | US20040082636 Method for the prophylaxis or treatment of glomerulonephritis |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082600 Bioavailability; oral administering; cardiovascular disorders; sexual disorders |
| 04/29/2004 | US20040082596 Novel carbamate-substituted pyrazolopyridine derivatives |
| 04/29/2004 | US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082556 Inhibitors of type 5 and type 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082531 Containing a transcription regulatory sequence derived from Human Cytomegalovirus major immediate early gene that includes exon 1, but not intron A; use of such vectors in vaccine and pharmaceutical compositions and gene therapy |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081688 Comprising a drug, a lipid matrix and a surfactant characterized in that said drug is a peptide or a protein and lipid matrix has a monoglyceride content which is at least 70% w/w |
| 04/29/2004 | US20040081673 Compositions and methods for the treatment of skin damage |
| 04/29/2004 | US20040081624 Mixture containing high volatility carrier; vaporization; mixing with air |
| 04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
| 04/29/2004 | CA2502027A1 A method of treating vasomotor symptoms comprising a compound having norepinephrine reuptake inhibitor activity and 5-ht2a antagonistic activity |
| 04/28/2004 | EP1413332A1 Use of 2,5-dihydroxybenzenesulphonic acid derivatives in the production of a medicament used to potentiate the effect of other drugs in the treatment of erectile dysfunction |
| 04/28/2004 | EP1412757A2 Method for identification of proteins from intracellular bacteria |
| 04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412363A1 Gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411971A1 Use of long pentraxin ptx3 for treating female infertility |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 04/28/2004 | EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 04/28/2004 | EP1411916A2 Methods and materials for the treatment of testosterone deficiency in men |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | CN1492872A Tricycle quinolinone and tricycle quinoline as androgen receptor modulator compounds |
| 04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1491685A Contraceptive medicine recipe good for health |
| 04/28/2004 | CN1491676A Percutaneous or oral contraceptive, abortion and sterilizing composition |
| 04/28/2004 | CN1491675A Medicine for treating cow mammitis |
| 04/28/2004 | CN1491673A Guihuangshanjia capsule and its preparing method |
| 04/28/2004 | CN1491665A Compound povidone iodine external use medicine |
| 04/28/2004 | CN1491656A Medicinal use of asiatic centella extract containing asiaticoside and hydroxy asiaticoside |